The Lyfebulb–UnitedHealth Group Innovation Challenge will bring together Patient Entrepreneurs with key opinion leaders, patient advocates, and leadership from UnitedHealth Group as well as Lyfebulb to promote awareness, discussions, and connections around depression and anxiety, as well as innovation in the care of those affected.
Because they are personally motivated by their own disease, or that of a loved one, Patient Entrepreneurs have a unique ability to create value-added solutions beyond therapy. Our aim is to support user-driven innovation and provide a laser-focus on solutions for providing a higher quality of life for those living with depression or anxiety.
The award is open to Patient Entrepreneurs developing companies using healthcare information technology, medical devices, diagnostics, and/or consumer products or services that disrupt and shape the future care and management of patients with depression or anxiety.
You are eligible to apply for the 2019 Lyfebulb-UnitedHealth Group Innovation Challenge if:
The judging panel will look for evidence in the following categories:
Lyfebulb is a chronic disease-focused, patient empowerment platform that connects patients and industry (manufacturers and payers) to support user-driven innovation. Lyfebulb promotes a healthy, take-charge lifestyle for those affected by chronic disease. Grounded with its strong foundation in diabetes, the company has expanded disease states covered into cancer, inflammatory bowel disease, multiple sclerosis, and depression/anxiety.
UnitedHealth Group (NYSE: UNH) is a diversified health care company dedicated to helping people live healthier lives and helping to make the health system work better for everyone. UnitedHealth Group offers a broad spectrum of products and services through two distinct platforms: UnitedHealthcare, which provides health care coverage and benefits services; and Optum, which provides information and technology-enabled health services. For more information, visit UnitedHealth Group at unitedhealthgroup.com or follow @UnitedHealthGrp on Twitter.